Cubist Systematic Strategies, LLC Danaher Corp Put Options Transaction History

Cubist Systematic Strategies, LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$235.51 - $267.98 $3.2 Million - $3.64 Million	-13,600 Reduced 70.47%	5,700 $1.42 Million
Q1 2024 May 15, 2024	SELL	$224.58 - $256.19 $2.99 Million - $3.41 Million	-13,300 Reduced 40.8%	19,300 $4.82 Million
Q4 2023 Feb 14, 2024	BUY	$185.1 - $233.13 $2 Million - $2.52 Million	10,800 Added 49.54%	32,600 $7.54 Million
Q3 2023 Nov 14, 2023	SELL	$233.08 - $265.59 $2.73 Million - $3.11 Million	-11,700 Reduced 34.93%	21,800 $5.41 Million
Q2 2023 Aug 14, 2023	BUY	$224.99 - $256.14 $3.06 Million - $3.48 Million	13,600 Added 68.34%	33,500 $8.04 Million
Q1 2023 May 15, 2023	BUY	$239.75 - $277.0 $527,450 - $609,400	2,200 Added 12.43%	19,900 $5.02 Million
Q4 2022 Feb 14, 2023	BUY	$241.42 - $282.29 $3.62 Million - $4.23 Million	15,000 Added 555.56%	17,700 $4.7 Million
Q3 2022 Nov 14, 2022	SELL	$247.06 - $1507.4 $5.34 Million - $32.6 Million	-21,600 Reduced 88.89%	2,700 $697,000
Q2 2022 Aug 15, 2022	BUY	$237.11 - $299.66 $5.76 Million - $7.28 Million	24,300 New	24,300 $6.16 Million

2,510

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $172B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.